|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Opioid Litigation: Evading the Widening Crosshairsover 7 years ago
Patient & Customer-Centric Commercializationover 7 years ago
Compliance: The Critical Cog in Pharma Machineover 7 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysover 7 years ago
A Seat at the Strategy Tableover 7 years ago
Regulatory Innovation Generates Breakthroughsover 7 years ago
China’s Biopharma Rise: Opportunities and ThreatsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
4
The GLP-1 Gold Rush
5
